Lifeboat Foundation

University of Maryland researchers analyzed an evolutionary tree reconstructed from the DNA of a majority of known bat species and found four bat lineages that exhibit extreme longevity. They also identified, for the first time, two life history features that predict extended life spans in bats.

Their work is described in a research paper, published in the April 10, 2019 issue of the journal Biology Letters, which concluded that horseshoe bats, long-eared bats, the common vampire bat and at least one lineage of mouse-eared bats all live at least four times longer than other, similarly sized mammals. The researchers also found that a high-latitude home range and larger males than females can be used to predict a given bat species’ life span.

“Scientists are very interested in finding closely related species in which one is long lived and one is short lived, because it implies that there has been some recent change to allow one species to live longer,” said Gerald Wilkinson, a biology professor at UMD and lead author of the paper. “This study provides multiple cases of closely related species with varying longevity, which gives us many opportunities to make comparisons and look for some underlying mechanism that would allow some species to live so long.”

Dr. Alan Green’s patients travel from around the country to his tiny practice in Queens, N.Y., lured by the prospect of longer lives.

Over the past two years, more than 200 patients have flocked to see Green after learning that two drugs he prescribes could possibly stave off aging. One 95-year-old was so intent on keeping her appointment that she asked her son to drive her from Maryland after a snowstorm had closed the schools.

Green is among a small but growing number of doctors who prescribe drugs “off-label” for their possible anti-aging effects. Metformin is typically prescribed for diabetes, and rapamycin prevents organ rejection after a transplant, but doctors can prescribe drugs off-label for other purposes — in this case, for “aging.”

Continue reading “The surprising way some people are fighting aging” »

A groundbreaking new cell reprogramming device can turn existing cells into any other type of cell, repairing tissue and organs in mice.

LA JOLLA—(June 6, 2019) Scientists once thought that neurons, or possibly heart cells, were the oldest cells in the body. Now, Salk Institute researchers have discovered that the mouse brain, liver and pancreas contain populations of cells and proteins with extremely long lifespans—some as old as neurons. The findings, demonstrating “age mosaicism,” were published in Cell Metabolism on June 6, 2019. The team’s methods could be applied to nearly any tissue in the body to provide valuable information about lifelong function of non-dividing cells and how cells lose control over the quality and integrity of proteins and important cell structures during aging.

Putting a bit of positive spin on Birthdays and why you should probably see them as a good thing in the context of aging research.

Not so long ago, it was my 44th birthday, and I’ve finally decided to write something that I’ve been reflecting on for a while. To some people, a birthday is a cause for celebration; for others, it is viewed as a bad thing.

Yes, if you take the negative view, you could see it as simply a reminder of being another year older and another year closer to the grave. However, this is not how I see it; in fact, I think quite the opposite. I see it as another year closer to our goal: the defeat of age-related diseases due to the progress of rejuvenation biotechnology that offers longer and healthier lives.

Continue reading “Why I Am Future Positive on My Birthday” »

David A. Sinclair, Ph.D., A.O. is an Australian biologist and a Professor in the Department of Genetics and co-Director of the Paul F. Glenn Center for the Biology of Aging at Harvard Medical School. He is best known for his work on understanding why we age and how to slow its effects. He obtained his Ph.D. in Molecular Genetics at the University of New South Wales, Sydney, and received the Australian Commonwealth Prize. In 1995, he received a Ph.D. in Molecular Genetics then worked as a postdoctoral researcher at the Massachusetts Institute of Technology with Leonard Guarente. Since 1999 he has been a tenured professor in the Genetics Department of Harvard Medical School.

Dr. Sinclair is co-founder of several biotechnology companies (Sirtris, Ovascience, Genocea, Cohbar, MetroBiotech, ArcBio, Liberty Biosecurity) and is on the boards of several others. He is also co-founder and co-chief editor of the journal Aging. His work is featured in five books, two documentary movies, 60 Minutes, Morgan Freeman’s “Through the Wormhole” and other media.

Continue reading “David Sinclair – Slowing down Aging (VIDEO)” »

Medicine’s ever-increasing focus on longevity is bad for society, says a prominent physician. (But, who’d voluntarily give up those bonus years?)

Seamus O’Mahony

Today, we wish to highlight a new open access publication in which the researchers take a novel approach to the regeneration of the thymus, a small but vitally important organ that is key to our immune system.

The thymus shrinks as we age

The thymus is one of the most important organs in the body, and it is where thymocytes produced in the bone marrow travel to become new T cells before being trained in the lymph nodes to become the defenders of the adaptive immune system. However, as we get older, the thymus increasingly turns to fat and starts to shrink, causing its ability to produce new T cells to fall dramatically. This process is known as thymic involution and actually begins shortly after puberty, so this is one aspect of aging that begins fairly early in life, although it is many decades later before its decline causes serious health issues.

Continue reading “Creating Thymus Organoids Using Tissue Engineering” »